In terminal patients, intravenous hydration is generally avoided because it can increase the risk of which outcome?

• A. Patient discomfort and respiratory distress
• B. Fluid overload without symptoms
• C. Immediate symptom relief
• D. No adverse effects

Answer: (A)

In end-of-life care, the aim is comfort, not extending life with burdensome interventions. Giving intravenous fluids to terminally ill patients can tip the balance toward fluid overload, which often manifests as edema and congestion. This overload can directly cause or worsen respiratory symptoms like shortness of breath, coughing, and chest tightness, making breathing more uncomfortable and distressing. The body's organs may already be operating at reduced capacity, so even small fluid gains can lead to pulmonary edema or congestive symptoms that significantly impair comfort. Because the potential for relief is limited and the risks to comfort and breathing are real, IV hydration is generally avoided.

Some might think hydration could quickly relieve thirst, but IV fluids rarely provide rapid comfort in this setting and commonly introduce new burdens such as swelling, breathlessness, or abdominal distension. Alternatives focus on keeping the patient comfortable, with measures like oral care, small sips if appropriate, and other comfort-oriented approaches rather than IV hydration.